Form 4 for PODD Insulet Corporation
Accepted 2021-10-04 00:00:00 ET · period of report 2021-08-31 · accession 0001127602-21-026440 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2021-10-04 | 2021-08-31 | PODD | Petrovic Shacey | Pres, CEO, Dir | G - Gift | $0.00 | -38.1K | 6,401 | -86% | $0 |
| DM | 2021-10-04 | 2021-10-01 | PODD | Petrovic Shacey | Pres, CEO, Dir | M - OptEx | $29.91 | +15.0K | 30.8K | +95% | +$448.7K |
| D | 2021-10-04 | 2021-10-01 | PODD | Petrovic Shacey | Pres, CEO, Dir | S - Sale+OE | $282.87 | -15.0K | 15.8K | -49% | -$4.24M |
| DM | 2021-10-04 | 2021-10-01 | PODD | Petrovic Shacey | Pres, CEO, Dir | M - OptEx | $0.00 | -15.0K | 37.1K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-31 | G | D | 18,596 | $0.00 | 68,899 | I By NG Trust | — | — | |
| 2 | Common | Common Stock | 2021-08-31 | G | A | 18,596 | $0.00 | 44,501 | I By SP Trust | — | — | |
| 3 | Common | Common Stock | 2021-08-31 | G | D | 38,100 | $0.00 | 6,401 | I By SP Trust | — | — | |
| 4 | Common | Common Stock | 2021-10-01 | M | A | 7,436 | $30.58 | 23,215 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. |
| 5 | Common | Common Stock | 2021-10-01 | M | A | 7,564 | $29.26 | 30,779 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. |
| 6 | Common | Common Stock | 2021-10-01 | S | D | 15,000 | $282.87 | 15,779 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. (F2) The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $278.50 to $287.67. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2021-10-01 | M | D | 7,436 | $0.00 | 0 | D | $30.58 · — to 2025-02-09 | 7,436 Common Stock | (F3) This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2021-10-01 | M | D | 7,564 | $0.00 | 37,070 | D | $29.26 · — to 2026-02-24 | 7,564 Common Stock | (F4) This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |